HomeCompareUSRI vs MRK

USRI vs MRK: Dividend Comparison 2026

USRI yields 400000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 USRI wins by $5.011119029548644e+32M in total portfolio value
10 years
USRI
USRI
● Live price
400000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.011119029548644e+32M
Annual income
$500,865,583,351,836,840,000,000,000,000,000,000,000.00
Full USRI calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — USRI vs MRK

📍 USRI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUSRIMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, USRI + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
USRI pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

USRI
Annual income on $10K today (after 15% tax)
$34,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$425,735,745,849,061,300,000,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, USRI beats the other by $425,735,745,849,061,300,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of USRI + MRK for your $10,000?

USRI: 50%MRK: 50%
100% MRK50/50100% USRI
Portfolio after 10yr
$2.505559514774322e+32M
Annual income
$250,432,791,675,918,420,000,000,000,000,000,000,000.00/yr
Blended yield
99.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

USRI
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

USRI buys
0
MRK buys
0
No recent congressional trades found for USRI or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUSRIMRK
Forward yield400000.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$5.011119029548644e+32M$56.8K
Annual income after 10y$500,865,583,351,836,840,000,000,000,000,000,000,000.00$9,798.13
Total dividends collected$5.010957816668433e+32M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: USRI vs MRK ($10,000, DRIP)

YearUSRI PortfolioUSRI Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$40,010,700$40,000,000.00$11,206$366.19+$40.00MUSRI
2$149,615,521,729$149,572,710,280.37$12,650$502.35+$149615.51MUSRI
3$522,880,052,725,200$522,719,964,116,949.25$14,407$694.19+$522880052.71MUSRI
4$1,707,862,989,289,045,000$1,707,303,507,632,628,700.00$16,585$967.82+$1707862989289.03MUSRI
5$5,213,509,402,845,684,000,000$5,211,681,989,447,144,000,000.00$19,342$1,363.89+$5213509402845684.00MUSRI
6$14,874,219,058,409,543,000,000,000$14,868,640,603,348,497,000,000,000.00$22,913$1,947.19+$14874219058409543680.00MUSRI
7$39,661,196,234,050,755,000,000,000,000$39,645,280,819,658,260,000,000,000,000.00$27,662$2,823.89+$3.966119623405075e+22MUSRI
8$98,838,436,350,327,300,000,000,000,000,000$98,795,998,870,356,880,000,000,000,000,000.00$34,159$4,173.35+$9.88384363503273e+25MUSRI
9$230,205,236,474,344,900,000,000,000,000,000,000$230,099,479,347,450,050,000,000,000,000,000,000.00$43,337$6,308.80+$2.302052364743449e+29MUSRI
10$501,111,902,954,864,400,000,000,000,000,000,000,000$500,865,583,351,836,840,000,000,000,000,000,000,000.00$56,776$9,798.13+$5.011119029548644e+32MUSRI

USRI vs MRK: Complete Analysis 2026

USRIStock

USA Recycling Industries, Inc. engages in the ownership, operation, and licensing of specialty recycling service centers primarily in North America. The company is involved in the collection of recyclable materials, such as scrap metals, used tires, used motor oil, and used batteries; provision of disposal services for other auto-related waste streams generated by the automotive service center industry; and sale of recyclable waste to end-user consumers. It provides specialty recycling programs to approximately 4,000 automotive service center locations; and services to various national automotive service center chain-store operations. The company also offers used motor oil and related lubricants to end users, including small to medium sized fuel blenders and refineries, as well as automotive and manufacturing markets. It has working relationships with customers operating in the steel production, tire recycling, used motor oil re-refinery, and battery production industries. The company is headquartered in Reading, Pennsylvania.

Full USRI Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this USRI vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

USRI vs SCHDUSRI vs JEPIUSRI vs OUSRI vs KOUSRI vs MAINUSRI vs JNJUSRI vs ABBVUSRI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.